Status:
COMPLETED
P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris
Lead Sponsor:
Novan, Inc.
Conditions:
Acne Vulgaris
Eligibility:
All Genders
12-40 years
Phase:
PHASE2
Brief Summary
This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a t...
Detailed Description
A randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical d...
Eligibility Criteria
Inclusion
- Moderate to severe acne
- 25-70 non-inflammatory lesions at Baseline
- 20-40 inflammatory lesions at Baseline
Exclusion
- Subjects with known allergy to any component of the test material or vehicle
- Women who are pregnant or nursing
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT02242760
Start Date
November 1 2014
End Date
August 1 2015
Last Update
May 31 2023
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Qst acne site #1
Hot Springs, Arkansas, United States, 71913
2
QST Site #118
Encinitas, California, United States, 92024
3
QST Site #111
San Diego, California, United States, 92123
4
QST Site #113
San Diego, California, United States, 92123